Aachen papers per year
Papers 539
-
Subcutaneous Daratumumab with Bortezomib, Cyclophosphamide, and Dexamethasone in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: 18-Month Analysis of the Phase 3 ANDROMEDA Study2021 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Raymond L. Comenzo, Giovanni O. Palladini, Efstathios Kastritis, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, +24 more
12citations -
Fixed-Duration Epcoritamab + R2 Drives Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: 2-Year Follow-up from Arm 2 of the Epcore NHL-2 Trial
Lorenzo Falchi, Anna Sureda, Sirpa Leppä, Joost S.P. Vermaat, Marcel Nijland, Jacob Haaber Christensen, +14 more
12citations -
Safety and efficacy of INCA033989, a novel first in class mutant calreticulin-specific monoclonal antibody, in patients with essential thrombocythemia2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Vikas Gupta, John O Mascarenhas, Haris Ali, David M. Ross, Abdulraheem Yacoub, Tania Jain, +27 more
10citations -
Enhanced α2-3–linked sialylation determines the extended half-life of CHO-rVWF2025 Blood article Biochemistry, Genetics and Molecular Biology Glycosylation and Glycoproteins Research Open access
Ciara Byrne, Soracha E. Ward, Jamie M. O’Sullivan, Alain Chion, Patrícia das Dores Lopes, Bogdan Baci, +13 more
10citations -
Stem Cell Collection with Daratumumab (DARA)-Based Regimens in Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) in the Griffin and Master Studies
Saurabh Chhabra, Natalie S. Callander, Luciano J. Costa, Jonathan L. Kaufman, Jacob P. Laubach, Douglas Weston Sborov, +24 more
9citations -
Fixed-Duration Epcoritamab + R-Mini-CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Ineligible for Full-Dose R-CHOP: Updated Results from Arm 8 of the Epcore NHL-2 Trial
Lori Ann Leslie, Chan Yoon Cheah, Franck Morschhauser, Justin M. Darrah, Joshua Brody, David Belada, +8 more
9citations -
A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy (BAT) in Patients with Intermediate-2 or High-Risk Myelofibrosis (MF) Refractory to Janus Kinase (JAK) Inhibitor
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Ruben A. Mesa, Rami S. Komrokji, Steffen Koschmieder, +10 more
8citations
Most active Aachen authors
-
Tim H. Brümmendorf 16,145 citations overall53 papers
-
Steffen Koschmieder 11,677 citations overall46 papers
-
Jens Panse 10,288 citations overall40 papers
-
Joost S.P. Vermaat 3,482 citations overall40 papers
-
Linda Köster 1,844 citations overall39 papers
-
Edgar Jost 3,752 citations overall31 papers
-
Dirk‐Jan Eikema 1,017 citations overall29 papers
-
Hendrik Veelken 10,266 citations overall25 papers
-
Fabian Beier 3,900 citations overall23 papers
-
Martina Margrit Crysandt 2,348 citations overall23 papers
-
Luuk A. Gras 5,079 citations overall21 papers
-
JESSICA T. VERMEULEN 10,466 citations overall20 papers
-
Liesbeth C. de Wreede 4,718 citations overall18 papers
-
Régis Peffault de Latour 20,463 citations overall14 papers
-
Antonio Maria Risitano 16,882 citations overall14 papers